Ambee Pharmaceuticals PLC

DSE:AMBEEPHA Stock Report

Market Cap: ৳1.9b

Ambee Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 2/6

Ambee Pharmaceuticals has a total shareholder equity of BDT24.6M and total debt of BDT445.4M, which brings its debt-to-equity ratio to 1813.9%. Its total assets and total liabilities are BDT556.0M and BDT531.5M respectively. Ambee Pharmaceuticals's EBIT is BDT13.2M making its interest coverage ratio 15.3. It has cash and short-term investments of BDT34.2M.

Key information

1,813.9%

Debt to equity ratio

৳445.37m

Debt

Interest coverage ratio15.3x
Cash৳34.24m
Equity৳24.55m
Total liabilities৳531.46m
Total assets৳556.02m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: AMBEEPHA's short term assets (BDT470.9M) do not cover its short term liabilities (BDT526.0M).

Long Term Liabilities: AMBEEPHA's short term assets (BDT470.9M) exceed its long term liabilities (BDT5.5M).


Debt to Equity History and Analysis

Debt Level: AMBEEPHA's net debt to equity ratio (1674.5%) is considered high.

Reducing Debt: AMBEEPHA's debt to equity ratio has increased from 190.9% to 1813.9% over the past 5 years.

Debt Coverage: AMBEEPHA's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: AMBEEPHA's interest payments on its debt are well covered by EBIT (15.3x coverage).


Balance Sheet


Discover healthy companies